← FDA Drug Approvals (Drugs@FDA)

MEPRON

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 1995-02-08

Drug application

FDA Application #
NDA020500
Application type
New Drug Application
Brand name
MEPRON
Generic name
ATOVAQUONE
Active ingredients
ATOVAQUONE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
GLAXOSMITHKLINE LLC
Manufacturer
GlaxoSmithKline LLC
First approval
1995-02-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown